Debate of the Decade: RCTs in the Era of Precision Oncology
How do you design clinical trials in the era of precision oncology? Are prospective randomized controlled trials necessary anymore? Drs. Ray Kurzrock, Vivek Subbiah, and Christopher Booth join Dr. Chadi Nabhan to answer these important questions.
Organoids Offer Insight Into Melanoma Drug Resistance
Clinical Predictors of Early Cutaneous Melanoma Recurrence
FDA Approves Mepolizumab as Add-On Treatment for COPD